✦ LIBER ✦

Determinants of drug response in a cisplatin-resistant human lung cancer cell line

Book ID: 122974757
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 168 KB
Volume: 7
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(91)90225-U

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determinants of Drug Response in a Cispl

Determinants of Drug Response in a Cisplatin-resistant Human Lung Cancer Cell Line

✍ Fujiwara, Yasuhiro ;Sugimoto, Yoshikazu ;Kasahara, Kazuo ;Bungo, Masami ;Yamakid 📂 Article 📅 1990 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 564 KB

Radiation sensitivities in various antic

Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line

✍ Fumihiro Oshita; Yasuhiro Fujiwara; Nagahiro Saijo 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 809 KB

Resistant mechanisms of cisplatin in hum

Resistant mechanisms of cisplatin in human lung adenocarcinoma cell line A549DDP

✍ Maocheng Zhan; Xuyi Liu; Peng Cai; Guangwei Xu 📂 Article 📅 1997 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 351 KB

559 Energy dependent reduction of cispla

559 Energy dependent reduction of cisplatin accumulation in a cisplatin-resistant human small cell lung cancer (SCLC) cell line

✍ Campling, B.G.; Jain, N.; Cole, S.P.C.; Deeley, R.G.; Gerlach, J.H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Establishment of a Cisplatin-Resistant H

Establishment of a Cisplatin-Resistant Human Ovarian Cancer Cell Line2

📂 Article 📅 1986 🏛 Oxford University Press 🌐 English ⚖ 511 KB

Establishment and characterization of ci

Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines

✍ Weon-Seon Hong; Nagahiro Saijo; Yasutsuna Sasaki; Koichi Minato; Hidehiko Nakano 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 639 KB

Human lung cancer sublines resistant t o cisplatin (CDDP) have been developed by continuously exposing cells to gradually increasing doses of CDDP and use of the limiting dilution technique. The cell lines used were PC-7, PC-9 and PC-14 (pulmonary adenocarcinoma) and H69 and N23 I (small-cell lung c